A light micrograph of breast cancer cells, which could one day be treated by targeting specific proteins on their surface CNRI/SCIENCE PHOTO LIBRARY
A new kind of medicine that destroys specific proteins on the surface of cells could lead to better therapies for conditions such as cancer.
The approach, devised by at the Dana-Farber Cancer Institute in Boston, Massachusetts, and her colleagues, involves using modified antibodies they call TransTACs to join a surface protein to another common protein that is involved in transporting iron into cells. The first protein then gets dragged inside the cell and destroyed.
This…
